梁瓈方 Emily LIANG

Emily Liang serves as General Manager, North East Asia at CENTOGENE, where she guides regional strategy and growth to expand access to high‑quality genetic diagnostics and precision medicine. She oversees commercial execution across key markets, aligning go‑to‑market plans, regulatory readiness, and operations to ensure reliable service, sustainable growth, and clear clinical impact. Working closely with global teams, she helps translate CENTOGENE’s multiomic capabilities into solutions for clinicians, healthcare providers, and patients.

Emily brings deep leadership experience across the life sciences, combining scientific foundation with business acumen to build teams, grow markets, and strengthen partnerships. Her background spans business development, channel and key account management, product launches, and market entry, underpinned by hands‑on expertise in biotechnology and genomics. She holds master’s degrees in biotechnology and business administration and is recognized for data‑driven planning, multilingual communication, and consistent, outcomes‑focused execution. Applying this breadth, she accelerates patient identification, improves diagnostic pathways, and deepens collaboration across North East Asia—advancing CENTOGENE’s mission with steady leadership and a collaborative, results‑oriented approach.